(S)-nicotine increases expression EXP 6480464 Nicotine results in increased expression of MSX1 mRNA CTD PMID:20339300 1-[(4-chlorophenyl)-phenylmethyl]-4-methylpiperazine increases expression EXP 6480464 chlorcyclizine results in increased expression of MSX1 mRNA CTD PMID:21058326 17beta-estradiol increases expression ISO MSX1 (Homo sapiens) 6480464 Estradiol results in increased expression of MSX1 mRNA CTD PMID:31614463 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO Msx1 (Mus musculus) 6480464 Tetrachlorodibenzodioxin affects the expression of MSX1 mRNA CTD PMID:24058054 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO Msx1 (Mus musculus) 6480464 Tetrachlorodibenzodioxin results in decreased expression of MSX1 mRNA CTD PMID:16922920 more ... 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO Msx1 (Mus musculus) 6480464 Tetrachlorodibenzodioxin promotes the reaction [tributyltin results in decreased expression of MSX1 mRNA] CTD PMID:22749964 4,4'-sulfonyldiphenol increases expression ISO Msx1 (Mus musculus) 6480464 bisphenol S results in increased expression of MSX1 mRNA CTD PMID:30951980 5-aza-2'-deoxycytidine increases expression ISO MSX1 (Homo sapiens) 6480464 Decitabine results in increased expression of MSX1 mRNA CTD PMID:16367923 6-propyl-2-thiouracil decreases expression EXP 6480464 Propylthiouracil results in decreased expression of MSX1 mRNA CTD PMID:25825206 6-propyl-2-thiouracil multiple interactions ISO Msx1 (Mus musculus) 6480464 [Propylthiouracil co-treated with Iodine deficiency] results in decreased expression of MSX1 mRNA CTD PMID:36706583 acrylamide decreases expression ISO Msx1 (Mus musculus) 6480464 Acrylamide results in decreased expression of MSX1 mRNA CTD PMID:35032568 aflatoxin B1 affects expression ISO MSX1 (Homo sapiens) 6480464 Aflatoxin B1 affects the expression of MSX1 protein CTD PMID:20106945 all-trans-retinoic acid increases expression ISO Msx1 (Mus musculus) 6480464 Tretinoin results in increased expression of MSX1 mRNA CTD PMID:16604517 all-trans-retinoic acid increases expression ISO MSX1 (Homo sapiens) 6480464 Tretinoin results in increased expression of MSX1 mRNA CTD PMID:17138961 and PMID:21934132 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of MSX1 mRNA CTD PMID:16483693 antirheumatic drug increases expression ISO MSX1 (Homo sapiens) 6480464 Antirheumatic Agents results in increased expression of MSX1 mRNA CTD PMID:24449571 aristolochic acid A increases expression ISO MSX1 (Homo sapiens) 6480464 aristolochic acid I results in increased expression of MSX1 mRNA CTD PMID:33212167 arsane increases methylation ISO MSX1 (Homo sapiens) 6480464 Arsenic results in increased methylation of MSX1 promoter CTD PMID:21291286 arsenic atom increases methylation ISO MSX1 (Homo sapiens) 6480464 Arsenic results in increased methylation of MSX1 promoter CTD PMID:21291286 arsenite(3-) increases methylation ISO MSX1 (Homo sapiens) 6480464 arsenite results in increased methylation of MSX1 promoter CTD PMID:23974009 belinostat increases expression ISO MSX1 (Homo sapiens) 6480464 belinostat results in increased expression of MSX1 mRNA CTD PMID:26272509 belinostat multiple interactions ISO MSX1 (Homo sapiens) 6480464 [NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MSX1 mRNA CTD PMID:27188386 benzo[a]pyrene affects methylation ISO MSX1 (Homo sapiens) 6480464 Benzo(a)pyrene affects the methylation of MSX1 promoter CTD PMID:27901495 benzo[a]pyrene decreases expression ISO MSX1 (Homo sapiens) 6480464 Benzo(a)pyrene results in decreased expression of MSX1 mRNA CTD PMID:30659931 bis(2-ethylhexyl) phthalate increases expression ISO MSX1 (Homo sapiens) 6480464 Diethylhexyl Phthalate results in increased expression of MSX1 mRNA CTD PMID:28412506 bis(2-ethylhexyl) phthalate decreases expression ISO MSX1 (Homo sapiens) 6480464 Diethylhexyl Phthalate results in decreased expression of MSX1 mRNA CTD PMID:31163220 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of MSX1 mRNA CTD PMID:25181051 bisphenol A increases methylation ISO MSX1 (Homo sapiens) 6480464 bisphenol A results in increased methylation of MSX1 gene CTD PMID:31601247 bisphenol A increases expression ISO Msx1 (Mus musculus) 6480464 bisphenol A results in increased expression of MSX1 mRNA CTD PMID:30951980 and PMID:32156529 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of MSX1 mRNA CTD PMID:30816183 and PMID:34947998 bisphenol A affects methylation ISO Msx1 (Mus musculus) 6480464 bisphenol A affects the methylation of MSX1 promoter CTD PMID:27334623 bisphenol F increases expression ISO Msx1 (Mus musculus) 6480464 bisphenol F results in increased expression of MSX1 mRNA CTD PMID:30951980 cannabidiol decreases expression ISO MSX1 (Homo sapiens) 6480464 Cannabidiol results in decreased expression of MSX1 mRNA CTD PMID:27918106 carbamazepine affects expression ISO MSX1 (Homo sapiens) 6480464 Carbamazepine affects the expression of MSX1 mRNA CTD PMID:25979313 choline multiple interactions ISO Msx1 (Mus musculus) 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of MSX1 gene CTD PMID:20938992 copper atom increases expression EXP 6480464 Copper results in increased expression of MSX1 mRNA CTD PMID:30556269 copper(0) increases expression EXP 6480464 Copper results in increased expression of MSX1 mRNA CTD PMID:30556269 copper(II) sulfate increases expression ISO MSX1 (Homo sapiens) 6480464 Copper Sulfate results in increased expression of MSX1 mRNA CTD PMID:19549813 Cuprizon increases expression EXP 6480464 Cuprizone results in increased expression of MSX1 mRNA CTD PMID:26577399 cyclosporin A increases expression ISO MSX1 (Homo sapiens) 6480464 Cyclosporine results in increased expression of MSX1 mRNA CTD PMID:20106945 cyproconazole decreases expression ISO Msx1 (Mus musculus) 6480464 cyproconazole results in decreased expression of MSX1 mRNA CTD PMID:22045034 cytarabine decreases expression ISO MSX1 (Homo sapiens) 6480464 Cytarabine results in decreased expression of MSX1 mRNA CTD PMID:21198554 DDT decreases expression EXP 6480464 DDT results in decreased expression of MSX1 mRNA CTD PMID:19797855 diiodine multiple interactions ISO Msx1 (Mus musculus) 6480464 [Propylthiouracil co-treated with Iodine deficiency] results in decreased expression of MSX1 mRNA CTD PMID:36706583 dimethylarsinous acid decreases expression ISO Msx1 (Mus musculus) 6480464 dimethylarsinous acid results in decreased expression of MSX1 protein CTD PMID:26024302 diuron decreases expression EXP 6480464 Diuron results in decreased expression of MSX1 mRNA CTD PMID:25152437 dorsomorphin multiple interactions ISO MSX1 (Homo sapiens) 6480464 [NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 doxorubicin decreases expression ISO MSX1 (Homo sapiens) 6480464 Doxorubicin results in decreased expression of MSX1 mRNA CTD PMID:29803840 entinostat increases expression ISO MSX1 (Homo sapiens) 6480464 entinostat results in increased expression of MSX1 mRNA CTD PMID:26272509 flavonoids increases expression EXP 6480464 Flavonoids results in increased expression of MSX1 mRNA CTD PMID:18035473 folic acid multiple interactions ISO Msx1 (Mus musculus) 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of MSX1 gene CTD PMID:20938992 formaldehyde increases expression ISO MSX1 (Homo sapiens) 6480464 Formaldehyde results in increased expression of MSX1 mRNA CTD PMID:20655997 furan decreases expression EXP 6480464 furan results in decreased expression of MSX1 mRNA CTD PMID:25539665 glycidol increases expression EXP 6480464 glycidol results in increased expression of MSX1 mRNA CTD PMID:24395379 hexaconazole decreases expression ISO Msx1 (Mus musculus) 6480464 hexaconazole results in decreased expression of MSX1 mRNA CTD PMID:22045034 L-methionine multiple interactions ISO Msx1 (Mus musculus) 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of MSX1 gene CTD PMID:20938992 Licochalcone B increases expression ISO MSX1 (Homo sapiens) 6480464 licochalcone B results in increased expression of MSX1 mRNA CTD PMID:33647349 mercury dibromide increases expression ISO MSX1 (Homo sapiens) 6480464 mercuric bromide results in increased expression of MSX1 mRNA CTD PMID:26272509 mercury dibromide multiple interactions ISO MSX1 (Homo sapiens) 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MSX1 mRNA CTD PMID:27188386 nicotine increases expression EXP 6480464 Nicotine results in increased expression of MSX1 mRNA CTD PMID:20339300 ozone multiple interactions ISO Msx1 (Mus musculus) 6480464 [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of MSX1 mRNA CTD PMID:34911549 p-chloromercuribenzoic acid increases expression ISO MSX1 (Homo sapiens) 6480464 p-Chloromercuribenzoic Acid results in increased expression of MSX1 mRNA CTD PMID:26272509 p-chloromercuribenzoic acid multiple interactions ISO MSX1 (Homo sapiens) 6480464 [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MSX1 mRNA CTD PMID:27188386 panobinostat multiple interactions ISO MSX1 (Homo sapiens) 6480464 [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MSX1 mRNA CTD PMID:27188386 panobinostat increases expression ISO MSX1 (Homo sapiens) 6480464 panobinostat results in increased expression of MSX1 mRNA CTD PMID:26272509 paracetamol increases expression ISO MSX1 (Homo sapiens) 6480464 Acetaminophen results in increased expression of MSX1 mRNA CTD PMID:21420995 and PMID:29067470 phenobarbital affects expression ISO MSX1 (Homo sapiens) 6480464 Phenobarbital affects the expression of MSX1 mRNA CTD PMID:19159669 phenylmercury acetate increases expression ISO MSX1 (Homo sapiens) 6480464 Phenylmercuric Acetate results in increased expression of MSX1 mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO MSX1 (Homo sapiens) 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MSX1 mRNA CTD PMID:27188386 quercetin decreases expression ISO MSX1 (Homo sapiens) 6480464 Quercetin results in decreased expression of MSX1 mRNA CTD PMID:21632981 quercetin decreases expression EXP 6480464 Quercetin results in decreased expression of MSX1 protein CTD PMID:28431985 retinyl acetate increases expression ISO Msx1 (Mus musculus) 6480464 retinol acetate results in increased expression of MSX1 mRNA CTD PMID:16772331 SB 431542 multiple interactions ISO MSX1 (Homo sapiens) 6480464 [NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 silver atom increases expression ISO MSX1 (Homo sapiens) 6480464 Silver results in increased expression of MSX1 mRNA CTD PMID:26551752 silver atom increases expression ISO Msx1 (Mus musculus) 6480464 Silver results in increased expression of MSX1 mRNA CTD PMID:27131904 silver(0) increases expression ISO MSX1 (Homo sapiens) 6480464 Silver results in increased expression of MSX1 mRNA CTD PMID:26551752 silver(0) increases expression ISO Msx1 (Mus musculus) 6480464 Silver results in increased expression of MSX1 mRNA CTD PMID:27131904 sodium arsenite multiple interactions ISO MSX1 (Homo sapiens) 6480464 monoisoamyl-2 and 3-dimercaptosuccinate inhibits the reaction [sodium arsenite results in decreased expression of MSX1 mRNA] CTD PMID:19615344 sodium arsenite increases expression ISO Msx1 (Mus musculus) 6480464 sodium arsenite results in increased expression of MSX1 mRNA CTD PMID:37682722 sodium arsenite decreases expression ISO Msx1 (Mus musculus) 6480464 sodium arsenite results in decreased expression of MSX1 mRNA and sodium arsenite results in decreased expression of MSX1 protein CTD PMID:26024302 sodium arsenite decreases expression ISO MSX1 (Homo sapiens) 6480464 sodium arsenite results in decreased expression of MSX1 mRNA CTD PMID:19615344 and PMID:34032870 sulindac sulfide decreases expression ISO MSX1 (Homo sapiens) 6480464 sulindac sulfide results in decreased expression of MSX1 mRNA and sulindac sulfide results in decreased expression of MSX1 protein CTD PMID:12734198 temozolomide increases expression ISO MSX1 (Homo sapiens) 6480464 Temozolomide results in increased expression of MSX1 mRNA CTD PMID:31758290 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of MSX1 mRNA CTD PMID:34492290 tributylstannane multiple interactions ISO Msx1 (Mus musculus) 6480464 Tetrachlorodibenzodioxin promotes the reaction [tributyltin results in decreased expression of MSX1 mRNA] CTD PMID:22749964 tributylstannane decreases expression ISO Msx1 (Mus musculus) 6480464 tributyltin results in decreased expression of MSX1 mRNA CTD PMID:22749964 trichostatin A increases expression ISO MSX1 (Homo sapiens) 6480464 trichostatin A results in increased expression of MSX1 mRNA CTD PMID:24935251 and PMID:26272509 trichostatin A multiple interactions ISO MSX1 (Homo sapiens) 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MSX1 mRNA CTD PMID:27188386 trimellitic anhydride decreases expression ISO Msx1 (Mus musculus) 6480464 trimellitic anhydride results in decreased expression of MSX1 mRNA CTD PMID:19042947 troglitazone increases expression ISO MSX1 (Homo sapiens) 6480464 troglitazone results in increased expression of MSX1 mRNA CTD PMID:19140230 urethane increases expression ISO MSX1 (Homo sapiens) 6480464 Urethane results in increased expression of MSX1 mRNA CTD PMID:28818685 valproic acid decreases expression ISO Msx1 (Mus musculus) 6480464 Valproic Acid results in decreased expression of MSX1 mRNA CTD PMID:19136453 and PMID:22045034 valproic acid decreases expression EXP 6480464 Valproic Acid results in decreased expression of MSX1 mRNA CTD PMID:34779009 valproic acid decreases expression ISO MSX1 (Homo sapiens) 6480464 Valproic Acid results in decreased expression of MSX1 mRNA CTD PMID:28001369 valproic acid multiple interactions ISO MSX1 (Homo sapiens) 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MSX1 mRNA CTD PMID:27188386 valproic acid increases expression ISO MSX1 (Homo sapiens) 6480464 Valproic Acid results in increased expression of MSX1 mRNA CTD PMID:23179753 more ... valproic acid affects expression ISO MSX1 (Homo sapiens) 6480464 Valproic Acid affects the expression of MSX1 mRNA CTD PMID:25979313 vorinostat increases expression ISO MSX1 (Homo sapiens) 6480464 vorinostat results in increased expression of MSX1 mRNA CTD PMID:26272509 vorinostat multiple interactions ISO MSX1 (Homo sapiens) 6480464 [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MSX1 mRNA CTD PMID:27188386 zinc atom multiple interactions ISO MSX1 (Homo sapiens) 6480464 [PCI 5002 co-treated with Zinc] results in increased expression of MSX1 mRNA CTD PMID:18593933 zinc(0) multiple interactions ISO MSX1 (Homo sapiens) 6480464 [PCI 5002 co-treated with Zinc] results in increased expression of MSX1 mRNA CTD PMID:18593933